What is a Fatal Flaw?
Before we discuss what steps an employer should take upon receiving a cancelled test notification, let’s take a closer look at what constitutes a fatal flaw during the collection process. According to 49 CFR Part 40 (Part 40), which is the federal regulation that governs how drug testing must be conducted for federal employees, the following scenarios are considered fatal flaws:- No Chain of Custody Form (CCF) accompanies the sample to the lab
- The CCF arrives at the lab without a sample even though a sample was collected
- The collector’s printed name and signature are omitted from the CCF
- Two separate collections are performed using one CCF
- The specimen ID numbers on the sample bottles do not match the numbers on the CCF
- The specimen bottle seals are broken, or appear to be tampered with
- There is an insufficient volume of urine to complete testing
What Happens if a Fatal Flaw is Committed?
Once a fatal flaw is committed, employers will usually receive a cancelled test notification. Employers then need to determine what the next steps are based on the reason for the test. In most cases, an employer must have a final result, whether positive or negative. What this means is that the donor will need to take a new test in order to achieve this outcome, usually for pre-employment, post-accident, or reasonable suspicion reasons for testing. Conversely, if a random test is cancelled due to a fatal flaw, an employer may not be authorized to retest that employee based on the applicable governing regulations. To clarify further, under federal regulations, if an employee’s random test is cancelled due to a collector error, the employer may not subject that individual to a retest. Employers need to be aware of the rules and regulations they must adhere to prior to making any retest decision.Why Else Can a Drug Test Be Cancelled?
Outside of fatal flaws committed due to collector error, a drug test may be cancelled for other reasons. For example, if a laboratory determines that a sample is invalid for any reason, it is likely that they will reject the sample for testing. This usually will be reported to a Medical Review Officer (MRO), who will then report the cancelled test outcome to the employer accompanied with further instruction for retesting. Depending on what regulations, policies, or guidelines an employer is responsible for adhering to, it is important that they are aware of the rules and requirements pertaining to cancelled tests. Cancelled tests are problematic to employers as they often lead to retests, increased costs, time delays, or other inconveniences associated with fatal flaws. The competency of a collector or collection facility is not something that can be controlled by the employer, so it is important to understand how to handle a cancelled test. © 2010-2021 The Current Consulting Group, LLC – No portion of this article may be reproduced, retransmitted, posted on a website, or used in any manner without the written consent of the Current Consulting Group, LLC. When permission is granted to reproduce this article in any way, full attribution to the author and copyright holder is required.Let's start a conversation
At ClearStar, we are committed to your success. An important part of your employment screening program involves compliance with various laws and regulations, which is why we are providing information regarding screening requirements in certain countries, region, etc. While we are happy to provide you with this information, it is your responsibility to comply with applicable laws and to understand how such information pertains to your employment screening program. The foregoing information is not offered as legal advice but is instead offered for informational purposes. ClearStar is not a law firm and does not offer legal advice and this communication does not form an attorney client relationship. The foregoing information is therefore not intended as a substitute for the legal advice of a lawyer knowledgeable of the user’s individual circumstances or to provide legal advice. ClearStar makes no assurances regarding the accuracy, completeness, or utility of the information contained in this publication. Legislative, regulatory and case law developments regularly impact on general research and this area is evolving rapidly. ClearStar expressly disclaim any warranties or responsibility or damages associated with or arising out of the information provided herein.